在癌症治疗中,药剂师对新兴的T细胞参与双特异性疗法的看法
Donald C Moore1, Naomi Digiantonio2, Carolyn J Oxencis3
1Atrium Health Levine Cancer Institute, Charlotte, NC, USA.
概括
新的双特异性T细胞参与疗法提供了新的癌症治疗方法. 药剂师在管理这些免疫疗法中发挥着关键作用,解决诸如细胞因子释放综合征等挑战.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 药理学 药理学是指药理学的学科.
背景情况:
- 癌症免疫疗法的重大进展.
- 双特异性T细胞参与治疗是一种新兴的药物类别.
- 这些疗法将瘤抗原和CD3与T细胞结合起来,启动免疫反应.
研究的目的:
- 概述新双特异性疗法的药理学,疗效和安全性.
- 概述剂量,管理和运行方面的考虑.
- 强调药剂师对管理这些新型癌症治疗的看法.
主要方法:
- 对药理学,疗效和安全性数据的审查.
- 对剂量和使用指南的分析.
- 探索运营挑战和药剂师角色.
主要成果:
- 几种双特异性疗法已被批准用于各种癌症 (例如,epcoritamab,glofitamab,mosunetuzumab,tebentafusp,teclistamab).
- 已获批准用于扩散性大B细胞淋巴瘤,卵泡淋巴瘤,乳膜黑色素瘤和多发性骨髓瘤.
- 潜在的细胞因子释放综合征需要特定的监测和管理策略.
结论:
- 双特异性疗法正在改变癌症治疗,特别是血液性恶性瘤.
- 运营挑战包括剂量升级,住院和细胞因子释放综合征预防.
- 医疗系统药剂师对于这些新兴疗法的运营和管理至关重要.
相关概念视频
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Vaccines
367
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
367


